Literature DB >> 23303851

Alzheimer disease and risk of stroke: a population-based cohort study.

Nai-Fang Chi1, Li-Nien Chien, Hsiao-Lun Ku, Chaur-Jong Hu, Hung-Yi Chiou.   

Abstract

OBJECTIVE: To investigate the risk of stroke in patients clinically diagnosed with Alzheimer disease (AD) compared with non-AD patients with similar vascular risk factors.
METHODS: Using data obtained from Taiwan's National Health Insurance Research Database, we evaluated the risk of ischemic stroke (IS) and intracerebral hemorrhage (ICH) in patients with AD (n = 980) who had no history of stroke, vascular dementia, or other cerebral degenerative diseases. Our evaluation period spanned from 2000 to 2010. We performed a 1:5 case-control matched analysis, in which cases were matched to controls according to their estimated propensity scores, which were based on demographics and existing vascular risk factors. This approach reduced selection bias. Cox proportional hazards regression analysis was then used to estimate the risk of IS and ICH in AD, conditional for matched pairs.
RESULTS: Overall, patients with AD had a higher risk of IS and ICH than those without AD. The incidence of IS in AD cases and non-AD controls was 37.8 and 23.2 per 1,000 person-years, with an adjusted hazard ratio of 1.66 (95% confidence interval, 1.37-2.01, p < 0.001). The incidence of ICH in AD cases and non-AD controls was 5.2 and 3.0 per 1,000 person-years, with an adjusted hazard ratio of 1.70 (95% confidence interval, 1.03-2.79, p = 0.037).
CONCLUSION: Clinical diagnosis of AD is associated with considerably increased risk of stroke development.

Entities:  

Mesh:

Year:  2013        PMID: 23303851     DOI: 10.1212/WNL.0b013e31828250af

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

Review 1.  Cognitive impairment and risk of future stroke: a systematic review and meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Keun-Sik Hong; Yi-Ling Wu; Hsing-Cheng Liu; Neal M Rao; Bruce Ovbiagele
Journal:  CMAJ       Date:  2014-08-25       Impact factor: 8.262

Review 2.  Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

Authors:  Kellen E Haley; Steven M Greenberg; M Edip Gurol
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

3.  Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability.

Authors:  Georgette L Suidan; Pradeep K Singh; Sunita Patel-Hett; Zu-Lin Chen; Dmitri Volfson; Hitomi Yamamoto-Imoto; Erin H Norris; Robert D Bell; Sidney Strickland
Journal:  Blood Adv       Date:  2018-05-08

4.  Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.

Authors:  Dominic D Quintana; Jorge A Garcia; Yamini Anantula; Stephanie L Rellick; Elizabeth B Engler-Chiurazzi; Saumyendra N Sarkar; Candice M Brown; James W Simpkins
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 5.  Cerebrovascular Alterations in Alzheimer Disease.

Authors:  Costantino Iadecola; Rebecca F Gottesman
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

6.  Brain arterial aging and its relationship to Alzheimer dementia.

Authors:  Jose Gutierrez; Lawrence Honig; Mitchell S V Elkind; Jay P Mohr; James Goldman; Andrew J Dwork; Susan Morgello; Randolph S Marshall
Journal:  Neurology       Date:  2016-03-16       Impact factor: 9.910

7.  Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice.

Authors:  Zu-Lin Chen; Alexey S Revenko; Pradeep Singh; A Robert MacLeod; Erin H Norris; Sidney Strickland
Journal:  Blood       Date:  2017-02-27       Impact factor: 22.113

8.  Vascular and Metabolic Factors in Alzheimer's Disease and Related Dementias: Introduction.

Authors:  Costantino Iadecola
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

9.  The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.

Authors:  D Zamolodchikov; T Renné; S Strickland
Journal:  J Thromb Haemost       Date:  2016-02-29       Impact factor: 5.824

10.  The association of depression, cognitive impairment without dementia, and dementia with risk of ischemic stroke: a cohort study.

Authors:  Dimitry S Davydow; Deborah A Levine; Kara Zivin; Wayne J Katon; Kenneth M Langa
Journal:  Psychosom Med       Date:  2015 Feb-Mar       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.